-
A prospective, open-label safety and efficacy study of combination treatment with melphalan, arsenic trioxide, and ascorbic acid in patients with relapsed or refractory multiple myeloma.
Institute for Myeloma and Bone Cancer Research and Oncotherapeutics, Los Angeles, CA, USA.
PMID: 15453931 [PubMed - indexed for MEDLINE]
-